Text Size: A- A+ Facebook Twitter LinkedIn YouTube

Breaking News



Format: 04/16/2014
Format: 04/16/2014


KDKA-TV: New Study Looks At Breast Cancer Drugs

Tuesday, April 20th, 2010

 Preventing breast cancer with drugs can be challenging, but a new study at Allegheny General Hospital may shed some light on a couple of treatment options.

One option is Tamoxifen. It works, but with a small increased risk for blood clots and uterine cancer.

"In someone who is otherwise healthy, it would prove to be a barrier," Dr. D. Lawrence Wickerham of the Allegheny General Hospital's Breast Center said.

Local researchers compared the chemically similar drug for thinning bones Raloxifene.

Both Tamoxifen and Raloxifene block the effect of the hormone estrogen on breast tissue.

Norma Kreutz was one of the people who took part in the study.

"I didn't know at the time. For the five years the study was going on, but after they did the unblinding, I was told I was on the Raloxifene," Kreutz said.

To read more, visit the KDKA website.

West Penn Allegheny Health System
Tell us who you are:

What areas do you use on our website?*
(select more than one if it applies)

Did you find what you were looking for?

Would you refer others to our website?

Can we contact you for future questions?

CAPTCHA math question:* 6 + 3 =

Thank you for completing the West Penn Allegheny Health System website survey.
We value your feedback and comments.